Cabot (NYSE:CBT) CEO Sean Keohane Sells 134,895 Shares

Key Points

• CEO Sean Keohane sold 134,895 Cabot shares at an average price of $85, generating $11.47 million. His remaining stake fell 25.03% to 404,134 shares.
• Cabot’s latest quarterly results slightly exceeded expectations, with earnings of $1.67 per share and revenue of $982 million, up 6.4% year over year. The company guided to fiscal 2026 earnings of $6.15–$6.45 per share.
• Cabot declared a quarterly dividend of $0.4725 per share, equivalent to $1.89 annually and a 2.3% yield. Analysts maintain a consensus “Hold” rating with an average price target of $89, compared with a recent share price of $82.72.

Cabot Corporation (NYSE:CBT - Get Free Report) CEO Sean Keohane sold 134,895 shares of the business's stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the transaction, the chief executive officer owned 404,134 shares in the company, valued at $34,351,390. This represents a 25.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Cabot Stock Performance

NYSE:CBT traded down $0.93 during mid-day trading on Monday, hitting $82.72. The stock had a trading volume of 351,206 shares, compared to its average volume of 470,451. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $94.53. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47. The stock has a market cap of $4.27 billion, a price-to-earnings ratio of 23.30, a PEG ratio of 10.98 and a beta of 0.84. The company's 50 day simple moving average is $87.62 and its 200 day simple moving average is $81.24.

Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, topping analysts' consensus estimates of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The firm had revenue of $982.00 million for the quarter, compared to the consensus estimate of $943.16 million. During the same quarter in the previous year, the business earned $1.90 earnings per share. The business's revenue was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, equities research analysts forecast that Cabot Corporation will post 6.35 earnings per share for the current year.

Cabot Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be given a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Friday, August 28th. Cabot's payout ratio is 53.24%.

Analysts Set New Price Targets

A number of research firms have recently issued reports on CBT. Wall Street Zen upgraded shares of Cabot from a "hold" rating to a "buy" rating in a research note on Sunday, August 9th. Mizuho increased their price target on shares of Cabot from $80.00 to $90.00 and gave the company a "neutral" rating in a report on Thursday, June 25th. Weiss Ratings restated a "hold (c)" rating on shares of Cabot in a report on Friday, August 21st. UBS Group decreased their price objective on Cabot from $97.00 to $92.00 and set a "neutral" rating on the stock in a report on Wednesday, August 5th. Finally, JPMorgan Chase & Co. increased their price objective on Cabot from $70.00 to $78.00 and gave the stock an "underweight" rating in a research report on Friday, August 7th. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, Cabot presently has an average rating of "Hold" and an average target price of $89.00.

Institutional Investors Weigh In On Cabot

A number of large investors have recently added to or reduced their stakes in CBT. Northwestern Mutual Wealth Management Co. acquired a new position in Cabot in the second quarter valued at about $33,000. Rothschild Investment LLC grew its stake in Cabot by 170.4% during the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company's stock worth $27,000 after buying an additional 259 shares in the last quarter. Geneos Wealth Management Inc. increased its holdings in Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company's stock valued at $38,000 after buying an additional 364 shares during the period. Global Retirement Partners LLC increased its holdings in Cabot by 1,606.9% in the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company's stock valued at $33,000 after buying an additional 466 shares during the period. Finally, Danske Bank A S acquired a new position in shares of Cabot in the 3rd quarter valued at approximately $38,000. Institutional investors and hedge funds own 93.18% of the company's stock.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source